nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—melanoma	0.841	1	CbGaD
Framycetin—CXCR4—endothelium—melanoma	0.0079	0.266	CbGeAlD
Framycetin—CXCR4—blood vessel—melanoma	0.00729	0.245	CbGeAlD
Framycetin—CXCR4—eye—melanoma	0.00388	0.13	CbGeAlD
Framycetin—CXCR4—retina—melanoma	0.00384	0.129	CbGeAlD
Framycetin—CXCR4—mammalian vulva—melanoma	0.00308	0.104	CbGeAlD
Framycetin—CXCR4—head—melanoma	0.0022	0.0741	CbGeAlD
Framycetin—Ototoxicity—Docetaxel—melanoma	0.00194	0.11	CcSEcCtD
Framycetin—Nephrotoxicity—Carmustine—melanoma	0.00191	0.108	CcSEcCtD
Framycetin—CXCR4—lymph node—melanoma	0.00154	0.0519	CbGeAlD
Framycetin—Impaired healing—Carmustine—melanoma	0.0014	0.0797	CcSEcCtD
Framycetin—Nephropathy toxic—Bleomycin—melanoma	0.00121	0.0687	CcSEcCtD
Framycetin—Nephropathy toxic—Carmustine—melanoma	0.00106	0.06	CcSEcCtD
Framycetin—Viral infection—Temozolomide—melanoma	0.000649	0.0369	CcSEcCtD
Framycetin—Erythema—Vemurafenib—melanoma	0.000501	0.0285	CcSEcCtD
Framycetin—Swelling—Carmustine—melanoma	0.000499	0.0283	CcSEcCtD
Framycetin—Anaphylactic shock—Vemurafenib—melanoma	0.000409	0.0232	CcSEcCtD
Framycetin—Infection—Vemurafenib—melanoma	0.000406	0.0231	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—TAS2R60—melanoma	0.000323	0.00288	CbGpPWpGaD
Framycetin—Swelling—Docetaxel—melanoma	0.000321	0.0182	CcSEcCtD
Framycetin—CXCR4—Disease—MYO7A—melanoma	0.000321	0.00286	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—melanoma	0.000318	0.00283	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—VEGFA—melanoma	0.000308	0.00274	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—F2R—melanoma	0.000306	0.00273	CbGpPWpGaD
Framycetin—Erythema—Bleomycin—melanoma	0.000304	0.0173	CcSEcCtD
Framycetin—Hypersensitivity—Vemurafenib—melanoma	0.000301	0.0171	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—EDN1—melanoma	0.000301	0.00268	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—EDNRB—melanoma	0.000296	0.00264	CbGpPWpGaD
Framycetin—Pruritus—Vemurafenib—melanoma	0.000289	0.0164	CcSEcCtD
Framycetin—Erythema—Dactinomycin—melanoma	0.000283	0.0161	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—MMP9—melanoma	0.000282	0.00252	CbGpPWpGaD
Framycetin—Diarrhoea—Vemurafenib—melanoma	0.00028	0.0159	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CXCR2—melanoma	0.000274	0.00244	CbGpPWpGaD
Framycetin—CXCR4—Disease—HS3ST5—melanoma	0.000273	0.00243	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL1—melanoma	0.00027	0.00241	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PLCB4—melanoma	0.00027	0.00241	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—WNT5A—melanoma	0.000265	0.00237	CbGpPWpGaD
Framycetin—Erythema—Carmustine—melanoma	0.000265	0.0151	CcSEcCtD
Framycetin—Vomiting—Vemurafenib—melanoma	0.00026	0.0148	CcSEcCtD
Framycetin—Erythema—Temozolomide—melanoma	0.000256	0.0146	CcSEcCtD
Framycetin—CXCR4—HIV Infection—ERCC2—melanoma	0.000252	0.00225	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—STAT3—melanoma	0.000251	0.00224	CbGpPWpGaD
Framycetin—Anaphylactic shock—Bleomycin—melanoma	0.000248	0.0141	CcSEcCtD
Framycetin—Infection—Bleomycin—melanoma	0.000246	0.014	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—PLCB4—melanoma	0.000245	0.00218	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL1—melanoma	0.000245	0.00218	CbGpPWpGaD
Framycetin—Nausea—Vemurafenib—melanoma	0.000243	0.0138	CcSEcCtD
Framycetin—CXCR4—HIV Infection—HLA-A—melanoma	0.000236	0.00211	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—RAC1—melanoma	0.000236	0.0021	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—F2R—melanoma	0.000233	0.00208	CbGpPWpGaD
Framycetin—Infection—Dactinomycin—melanoma	0.00023	0.013	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—F2RL1—melanoma	0.000229	0.00204	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—EDNRB—melanoma	0.000226	0.00201	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—DRAP1—melanoma	0.000224	0.002	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MYO7A—melanoma	0.000224	0.002	CbGpPWpGaD
Framycetin—CXCR4—HIV Life Cycle—CD4—melanoma	0.000221	0.00197	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GRM3—melanoma	0.000216	0.00192	CbGpPWpGaD
Framycetin—Infection—Carmustine—melanoma	0.000215	0.0122	CcSEcCtD
Framycetin—Anaphylactic shock—Temozolomide—melanoma	0.000209	0.0119	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—F2RL1—melanoma	0.000208	0.00186	CbGpPWpGaD
Framycetin—Infection—Temozolomide—melanoma	0.000208	0.0118	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—KISS1—melanoma	0.000204	0.00182	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—EDN1—melanoma	0.000202	0.0018	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CA—melanoma	0.000198	0.00177	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCR1—melanoma	0.000198	0.00177	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—AKT1—melanoma	0.000196	0.00175	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GRM3—melanoma	0.000196	0.00175	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—MC1R—melanoma	0.000195	0.00174	CbGpPWpGaD
Framycetin—CXCR4—Disease—CUL3—melanoma	0.000194	0.00173	CbGpPWpGaD
Framycetin—CXCR4—Disease—TRRAP—melanoma	0.000194	0.00173	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TAS2R60—melanoma	0.000191	0.0017	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKR1B10—melanoma	0.000189	0.00169	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GRM1—melanoma	0.000187	0.00167	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCR7—melanoma	0.000187	0.00167	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—KISS1—melanoma	0.000186	0.00166	CbGpPWpGaD
Framycetin—Hypersensitivity—Bleomycin—melanoma	0.000183	0.0104	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CXCR1—melanoma	0.00018	0.0016	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MC1R—melanoma	0.000177	0.00158	CbGpPWpGaD
Framycetin—Pruritus—Bleomycin—melanoma	0.000175	0.00996	CcSEcCtD
Framycetin—Erythema—Docetaxel—melanoma	0.00017	0.00968	CcSEcCtD
Framycetin—Hypersensitivity—Dactinomycin—melanoma	0.00017	0.00967	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—RHOB—melanoma	0.00017	0.00152	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCR7—melanoma	0.00017	0.00151	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GRM1—melanoma	0.00017	0.00151	CbGpPWpGaD
Framycetin—CXCR4—Disease—LUM—melanoma	0.000168	0.0015	CbGpPWpGaD
Framycetin—CXCR4—Disease—HPSE—melanoma	0.000165	0.00147	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL8—melanoma	0.000163	0.00145	CbGpPWpGaD
Framycetin—CXCR4—Disease—CUBN—melanoma	0.000162	0.00145	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—AKT1—melanoma	0.000162	0.00144	CbGpPWpGaD
Framycetin—Hypersensitivity—Carmustine—melanoma	0.000159	0.00905	CcSEcCtD
Framycetin—Diarrhoea—Dactinomycin—melanoma	0.000158	0.00898	CcSEcCtD
Framycetin—Vomiting—Bleomycin—melanoma	0.000158	0.00895	CcSEcCtD
Framycetin—CXCR4—Disease—CSPG4—melanoma	0.000157	0.0014	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCR2—melanoma	0.000155	0.00138	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—RHOB—melanoma	0.000154	0.00138	CbGpPWpGaD
Framycetin—Hypersensitivity—Temozolomide—melanoma	0.000154	0.00875	CcSEcCtD
Framycetin—CXCR4—Disease—RPS3—melanoma	0.000154	0.00137	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—EDN1—melanoma	0.000154	0.00137	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—CD4—melanoma	0.000152	0.00136	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—RAC2—melanoma	0.000152	0.00136	CbGpPWpGaD
Framycetin—CXCR4—Disease—SKI—melanoma	0.000152	0.00135	CbGpPWpGaD
Framycetin—Diarrhoea—Carmustine—melanoma	0.000148	0.00841	CcSEcCtD
Framycetin—Pruritus—Temozolomide—melanoma	0.000148	0.0084	CcSEcCtD
Framycetin—Nausea—Bleomycin—melanoma	0.000147	0.00836	CcSEcCtD
Framycetin—Vomiting—Dactinomycin—melanoma	0.000147	0.00835	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CXCL1—melanoma	0.000145	0.00129	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PLCB4—melanoma	0.000145	0.00129	CbGpPWpGaD
Framycetin—Diarrhoea—Temozolomide—melanoma	0.000143	0.00813	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CXCR2—melanoma	0.000141	0.00125	CbGpPWpGaD
Framycetin—Anaphylactic shock—Docetaxel—melanoma	0.000139	0.0079	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—RAC2—melanoma	0.000138	0.00123	CbGpPWpGaD
Framycetin—Infection—Docetaxel—melanoma	0.000138	0.00785	CcSEcCtD
Framycetin—Vomiting—Carmustine—melanoma	0.000138	0.00781	CcSEcCtD
Framycetin—Nausea—Dactinomycin—melanoma	0.000137	0.0078	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL8—melanoma	0.000137	0.00122	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—WNT5A—melanoma	0.000136	0.00121	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TRRAP—melanoma	0.000136	0.00121	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CUL3—melanoma	0.000136	0.00121	CbGpPWpGaD
Framycetin—Vomiting—Temozolomide—melanoma	0.000133	0.00755	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—AKR1B10—melanoma	0.000132	0.00118	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—F2R—melanoma	0.000132	0.00117	CbGpPWpGaD
Framycetin—Nausea—Carmustine—melanoma	0.000128	0.0073	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—EDNRB—melanoma	0.000128	0.00114	CbGpPWpGaD
Framycetin—CXCR4—Disease—HDAC6—melanoma	0.000125	0.00112	CbGpPWpGaD
Framycetin—Nausea—Temozolomide—melanoma	0.000124	0.00705	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—F2RL1—melanoma	0.000123	0.0011	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GNA11—melanoma	0.00012	0.00107	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GAB2—melanoma	0.00012	0.00107	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—F2R—melanoma	0.00012	0.00107	CbGpPWpGaD
Framycetin—CXCR4—Disease—NPPA—melanoma	0.000119	0.00106	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EDNRB—melanoma	0.000116	0.00103	CbGpPWpGaD
Framycetin—CXCR4—Disease—VCAN—melanoma	0.000116	0.00103	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRM3—melanoma	0.000116	0.00103	CbGpPWpGaD
Framycetin—CXCR4—Disease—WNT5A—melanoma	0.000115	0.00102	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GNAQ—melanoma	0.000112	0.000999	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KISS1—melanoma	0.00011	0.000978	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GAB2—melanoma	0.000109	0.000976	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GNA11—melanoma	0.000109	0.000976	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000109	0.000973	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SKI—melanoma	0.000106	0.000947	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCR1—melanoma	0.000106	0.000947	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MC1R—melanoma	0.000105	0.000933	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT3—melanoma	0.000103	0.000922	CbGpPWpGaD
Framycetin—Hypersensitivity—Docetaxel—melanoma	0.000102	0.00582	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—GNAQ—melanoma	0.000102	0.000907	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR7—melanoma	0.0001	0.000894	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRM1—melanoma	0.0001	0.000894	CbGpPWpGaD
Framycetin—Pruritus—Docetaxel—melanoma	9.84e-05	0.00559	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—SUFU—melanoma	9.77e-05	0.000871	CbGpPWpGaD
Framycetin—Diarrhoea—Docetaxel—melanoma	9.51e-05	0.0054	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—AKT3—melanoma	9.38e-05	0.000837	CbGpPWpGaD
Framycetin—CXCR4—Disease—GAB2—melanoma	9.23e-05	0.000823	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RHOB—melanoma	9.12e-05	0.000814	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BCL2L11—melanoma	9.12e-05	0.000814	CbGpPWpGaD
Framycetin—CXCR4—Disease—FASN—melanoma	9.03e-05	0.000805	CbGpPWpGaD
Framycetin—Vomiting—Docetaxel—melanoma	8.84e-05	0.00502	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—HDAC6—melanoma	8.76e-05	0.000782	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—EDN1—melanoma	8.68e-05	0.000774	CbGpPWpGaD
Framycetin—CXCR4—Disease—HDAC2—melanoma	8.68e-05	0.000774	CbGpPWpGaD
Framycetin—CXCR4—Disease—FOXO4—melanoma	8.68e-05	0.000774	CbGpPWpGaD
Framycetin—CXCR4—Disease—CD44—melanoma	8.58e-05	0.000765	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CSF2—melanoma	8.49e-05	0.000757	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCR2—melanoma	8.31e-05	0.000741	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL8—melanoma	8.3e-05	0.000741	CbGpPWpGaD
Framycetin—Nausea—Docetaxel—melanoma	8.26e-05	0.00469	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—RAC2—melanoma	8.17e-05	0.000729	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PRKCA—melanoma	8.14e-05	0.000726	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—WNT5A—melanoma	8.05e-05	0.000718	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFC—melanoma	8.05e-05	0.000718	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT3—melanoma	7.92e-05	0.000706	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EDN1—melanoma	7.88e-05	0.000703	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CSF2—melanoma	7.71e-05	0.000687	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—RAC1—melanoma	7.54e-05	0.000673	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PRKCA—melanoma	7.39e-05	0.000659	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAP2K2—melanoma	7.22e-05	0.000644	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—F2R—melanoma	7.06e-05	0.00063	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERBB4—melanoma	6.99e-05	0.000624	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN2B—melanoma	6.93e-05	0.000618	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—RAC1—melanoma	6.85e-05	0.000611	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EDNRB—melanoma	6.84e-05	0.00061	CbGpPWpGaD
Framycetin—CXCR4—Disease—CD86—melanoma	6.7e-05	0.000598	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTK2B—melanoma	6.64e-05	0.000592	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGF1—melanoma	6.5e-05	0.00058	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GAB2—melanoma	6.46e-05	0.000576	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GNA11—melanoma	6.46e-05	0.000576	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FLT1—melanoma	6.43e-05	0.000574	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CG—melanoma	6.37e-05	0.000568	CbGpPWpGaD
Framycetin—CXCR4—Disease—PDGFRA—melanoma	6.3e-05	0.000562	CbGpPWpGaD
Framycetin—CXCR4—Disease—PRKCA—melanoma	6.23e-05	0.000556	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERCC2—melanoma	6.18e-05	0.000551	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAP2K2—melanoma	6.09e-05	0.000543	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FOXO4—melanoma	6.07e-05	0.000542	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HDAC2—melanoma	6.07e-05	0.000542	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GNAQ—melanoma	6.01e-05	0.000536	CbGpPWpGaD
Framycetin—CXCR4—Disease—TERT—melanoma	5.79e-05	0.000517	CbGpPWpGaD
Framycetin—CXCR4—Disease—HLA-A—melanoma	5.79e-05	0.000517	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CG—melanoma	5.79e-05	0.000516	CbGpPWpGaD
Framycetin—CXCR4—Disease—RAC1—melanoma	5.78e-05	0.000515	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SYK—melanoma	5.65e-05	0.000504	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CD—melanoma	5.6e-05	0.0005	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT3—melanoma	5.54e-05	0.000494	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NGFR—melanoma	5.54e-05	0.000494	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ITGAV—melanoma	5.54e-05	0.000494	CbGpPWpGaD
Framycetin—CXCR4—Disease—HIF1A—melanoma	5.54e-05	0.000494	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SOCS1—melanoma	5.13e-05	0.000458	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAP2K1—melanoma	5.12e-05	0.000457	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—S100B—melanoma	5.12e-05	0.000457	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CD—melanoma	5.09e-05	0.000454	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS2—melanoma	5.04e-05	0.00045	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOTCH1—melanoma	4.99e-05	0.000445	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB4—melanoma	4.9e-05	0.000437	CbGpPWpGaD
Framycetin—CXCR4—Disease—CD80—melanoma	4.89e-05	0.000436	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CB—melanoma	4.88e-05	0.000436	CbGpPWpGaD
Framycetin—CXCR4—Disease—APC—melanoma	4.88e-05	0.000435	CbGpPWpGaD
Framycetin—CXCR4—Disease—KIT—melanoma	4.88e-05	0.000435	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN2B—melanoma	4.85e-05	0.000433	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGF—melanoma	4.83e-05	0.00043	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CD86—melanoma	4.69e-05	0.000419	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL8—melanoma	4.69e-05	0.000419	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EDN1—melanoma	4.66e-05	0.000415	CbGpPWpGaD
Framycetin—CXCR4—Disease—BRAF—melanoma	4.59e-05	0.000409	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CSF2—melanoma	4.55e-05	0.000406	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGF1—melanoma	4.55e-05	0.000406	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IL2—melanoma	4.48e-05	0.0004	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—E2F1—melanoma	4.45e-05	0.000397	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CB—melanoma	4.43e-05	0.000395	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDGFRA—melanoma	4.41e-05	0.000393	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ITGB3—melanoma	4.36e-05	0.000389	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKCA—melanoma	4.36e-05	0.000389	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAP2K1—melanoma	4.32e-05	0.000385	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CD—melanoma	4.29e-05	0.000383	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SPP1—melanoma	4.28e-05	0.000382	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAP2K2—melanoma	4.27e-05	0.000381	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL8—melanoma	4.26e-05	0.00038	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGF2—melanoma	4.11e-05	0.000366	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL2—melanoma	4.07e-05	0.000363	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TERT—melanoma	4.06e-05	0.000362	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RAC1—melanoma	4.05e-05	0.000361	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HIF1A—melanoma	3.88e-05	0.000346	CbGpPWpGaD
Framycetin—CXCR4—Disease—MDM2—melanoma	3.84e-05	0.000343	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERBB2—melanoma	3.79e-05	0.000338	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CB—melanoma	3.74e-05	0.000334	CbGpPWpGaD
Framycetin—CXCR4—Disease—CD4—melanoma	3.73e-05	0.000333	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KDR—melanoma	3.71e-05	0.000331	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTGS2—melanoma	3.71e-05	0.000331	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FN1—melanoma	3.57e-05	0.000319	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN1B—melanoma	3.51e-05	0.000313	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOTCH1—melanoma	3.5e-05	0.000312	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CD80—melanoma	3.42e-05	0.000305	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KIT—melanoma	3.42e-05	0.000305	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CG—melanoma	3.42e-05	0.000305	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APC—melanoma	3.42e-05	0.000305	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—NRAS—melanoma	3.42e-05	0.000305	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGF—melanoma	3.38e-05	0.000301	CbGpPWpGaD
Framycetin—CXCR4—Disease—CTNNB1—melanoma	3.32e-05	0.000296	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAPK3—melanoma	3.27e-05	0.000292	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN1A—melanoma	3.24e-05	0.000289	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTEN—melanoma	3.23e-05	0.000288	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BRAF—melanoma	3.21e-05	0.000287	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF1—melanoma	3.13e-05	0.000279	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAPK1—melanoma	3.12e-05	0.000278	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EGFR—melanoma	3.11e-05	0.000278	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAP2K1—melanoma	3.03e-05	0.00027	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CD—melanoma	3.01e-05	0.000268	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CA—melanoma	2.98e-05	0.000265	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—KRAS—melanoma	2.94e-05	0.000262	CbGpPWpGaD
Framycetin—CXCR4—Disease—STAT3—melanoma	2.89e-05	0.000258	CbGpPWpGaD
Framycetin—CXCR4—Disease—NRAS—melanoma	2.88e-05	0.000257	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGF2—melanoma	2.88e-05	0.000257	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAPK3—melanoma	2.76e-05	0.000246	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CA—melanoma	2.7e-05	0.000241	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MDM2—melanoma	2.69e-05	0.00024	CbGpPWpGaD
Framycetin—CXCR4—Disease—MYC—melanoma	2.69e-05	0.00024	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB2—melanoma	2.65e-05	0.000237	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAPK1—melanoma	2.63e-05	0.000234	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGFR—melanoma	2.63e-05	0.000234	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CB—melanoma	2.62e-05	0.000234	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL8—melanoma	2.52e-05	0.000225	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HRAS—melanoma	2.5e-05	0.000223	CbGpPWpGaD
Framycetin—CXCR4—Disease—KRAS—melanoma	2.48e-05	0.000221	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN1B—melanoma	2.46e-05	0.000219	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT1—melanoma	2.43e-05	0.000217	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASP3—melanoma	2.41e-05	0.000215	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL2—melanoma	2.41e-05	0.000215	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6—melanoma	2.39e-05	0.000213	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCND1—melanoma	2.35e-05	0.000209	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CTNNB1—melanoma	2.32e-05	0.000207	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CA—melanoma	2.28e-05	0.000203	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP9—melanoma	2.28e-05	0.000203	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN1A—melanoma	2.27e-05	0.000202	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTEN—melanoma	2.26e-05	0.000202	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NFKB1—melanoma	2.25e-05	0.000201	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT1—melanoma	2.21e-05	0.000197	CbGpPWpGaD
Framycetin—CXCR4—Disease—HRAS—melanoma	2.11e-05	0.000188	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—melanoma	2.04e-05	0.000182	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STAT3—melanoma	2.02e-05	0.000181	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NRAS—melanoma	2.02e-05	0.00018	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6—melanoma	2.02e-05	0.00018	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK3—melanoma	1.93e-05	0.000172	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MYC—melanoma	1.88e-05	0.000168	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT1—melanoma	1.86e-05	0.000166	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK1—melanoma	1.84e-05	0.000164	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGFR—melanoma	1.84e-05	0.000164	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KRAS—melanoma	1.74e-05	0.000155	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CA—melanoma	1.6e-05	0.000142	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TP53—melanoma	1.54e-05	0.000138	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HRAS—melanoma	1.48e-05	0.000132	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6—melanoma	1.41e-05	0.000126	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT1—melanoma	1.3e-05	0.000116	CbGpPWpGaD
